Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
Morning Overview on MSN
Mini human livers can now predict drug toxicity
Scientists have achieved a groundbreaking advancement in preclinical testing by growing mini human livers, known as organoids, that can predict toxic drug reactions. This significant development, ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
Liam Taylor, CEO, Axol Bioscience "We have built a unique set of products and services over the last decade to meet the growing requirements from the drug discovery and cosmetic industries to move ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...
Tahoe Therapeutics Raises $30M to Build World’s Largest Dataset for Training AI Models of Human Cell
SAN FRANCISCO--(BUSINESS WIRE)--Tahoe Therapeutics today announced $30 million in new funding to build the definitive foundational dataset for training Virtual Cell Models. With this, the team will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback